Jody L. Levasseur

发表

Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.

Kelvin E. Jones, I. M. Robertson, C. Soltys, 2017, American journal of physiology. Heart and circulatory physiology.

Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure

S. Verma, P. Light, J. Dyck, 2020, Circulation. Heart failure.

Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction

G. Lopaschuk, J. Levasseur, J. Dyck, 2018, Molecular Medicine.

Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.

J. Dyck, M. Sung, J. Levasseur, 2016, Cardiovascular research.

Characterisation of the Selective Reduced Uteroplacental Perfusion (sRUPP) Model of Preeclampsia

J. Dyck, S. Davidge, G. Fraser, 2019, Scientific Reports.

Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.

K. Gopal, D. Muoio, G. Lopaschuk, 2019, Cardiovascular research.

Effect of portal hypertension on splenic blood flow, intrasplenic extravasation and systemic blood pressure.

J. Levasseur, S. Kaufman, Jody L. Levasseur, 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heart

J. Dyck, M. Ferdaoussi, Zaid H Maayah, 2021, ESC heart failure.

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

V. Dolinsky, J. Dyck, S. Davidge, 2013, Biochimica et biophysica acta.

2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy

J. Dyck, A. Siraki, A. El-Kadi, 2018, Scientific Reports.

Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure

S. Verma, J. Dyck, J. Levasseur, 2017, JACC. Basic to translational science.

Resveratrol Treatment of Mice With Pressure-Overload–Induced Heart Failure Improves Diastolic Function and Cardiac Energy Metabolism

J. Dyck, M. Sung, Ty T. Kim, 2015, Circulation. Heart failure.

Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice.

D. Wishart, J. Dyck, M. Sung, 2018, American journal of physiology. Endocrinology and metabolism.

Intrauterine exposure to chronic hypoxia in the rat leads to progressive diastolic function and increased aortic stiffness from early postnatal developmental stages

L. Hornberger, S. Davidge, C. Sergi, 2020, Physiological reports.

Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure

J. Dyck, M. Ferdaoussi, Zaid H Maayah, 2020, Circulation. Heart failure.

Angiotensin‐converting enzyme 2 antagonizes angiotensin II‐induced pressor response and NADPH oxidase activation in Wistar–Kyoto rats and spontaneously hypertensive rats

J. Penninger, J. Levasseur, G. Oudit, 2013, Experimental physiology.

Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction–Induced Cardiac Hypertrophy in Rats

J. Dyck, A. El-Kadi, J. Levasseur, 2022, Journal of cardiovascular pharmacology.

Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.

J. Dyck, M. Sung, Ty T. Kim, 2017, American journal of physiology. Heart and circulatory physiology.

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

V. Dolinsky, J. Dyck, S. Davidge, 2013, Biochimica et biophysica acta.